Home » Healthcare » Vietnam Oral Solid Dosage Contract Manufacturing Market

Vietnam Oral Solid Dosage Contract Manufacturing Market By Type Outlook (Tablets, Capsules, Powders, Granules) By Mechanism Outlook (Immediate-release, Delayed-release, Controlled-release) By End-user (Large Size Companies, Medium & Small Size Companies); By Therapeutic Area (Cardiovascular, Central Nervous System (CNS), Gastrointestinal, Oncology, Others) – Growth, Future Prospects & Competitive Analysis, 2018 – 2032

Summary
Table Of Content

Vietnam Oral Solid Dosage Contract Manufacturing Market Overview

The Vietnam Oral Solid Dosage Contract Manufacturing market is expected to grow from USD 104.19 million in 2023 to USD 190.57 million by 2032, at a compound annual growth rate (CAGR) of 6.68%. The Vietnam Oral Solid Dosage Contract Manufacturing Market is experiencing significant growth, driven by the increasing demand for generic drugs and a rising aging population. This sector, focusing on the production of tablets, capsules, and powders, is benefiting from the cost-effectiveness and efficiency of Vietnamese Contract Manufacturing Organizations (CMOs). These factors, combined with supportive government policies towards the pharmaceutical sector and incentives for foreign investment, have created a fertile environment for market expansion. Furthermore, the evolving regulatory landscape in Vietnam, characterized by stricter quality control and compliance standards, is aligning the market more closely with international norms. This enhances Vietnam’s attractiveness as a destination for pharmaceutical companies seeking reliable contract manufacturing partners.

The market is characterized by a competitive landscape with both local and international players. Local CMOs are increasingly vying with foreign entities by offering competitive pricing and improving quality standards. Strategic collaborations between pharmaceutical companies and CMOs are common, focusing on leveraging local expertise and manufacturing capabilities. However, the market faces challenges such as maintaining regulatory compliance, quality standards, and the need for ongoing technological upgrades. Despite these challenges, the market offers significant opportunities, particularly in the export sector and for companies looking to cater to the global trend of outsourcing pharmaceutical manufacturing. With continuous investment in research and development and manufacturing capabilities, the Vietnam Oral Solid Dosage Contract Manufacturing Market is poised for continued growth and expansion, presenting a promising landscape for both established companies and new entrants.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Vietnam Oral Solid Dosage Contract Manufacturing Market Drivers

The Vietnam Oral Solid Dosage Contract Manufacturing Market is experiencing robust growth, primarily driven by the increasing demand for generic drugs. This surge is attributed to the growing aging population in Vietnam and the widespread need for affordable medication options, making oral solid dosage forms like tablets and capsules highly sought-after. Adding to this momentum is the cost-effectiveness of Vietnamese Contract Manufacturing Organizations (CMOs), which offer attractive solutions for drug production at lower costs. This affordability is a pivotal factor, enabling the production of high-quality medications at more economical prices, thus appealing to a broad range of pharmaceutical companies.

Supporting the market’s expansion are several key factors, including the Vietnamese government’s supportive stance towards the pharmaceutical sector. Through policies encouraging foreign investment and healthcare infrastructure improvement, coupled with regulatory reforms for quality control and alignment with international standards, the market’s growth is further accelerated. Additionally, Vietnam’s strategic location in Southeast Asia presents significant logistical advantages, facilitating both the import of raw materials and the export of finished products. The market is also bolstered by increased investment in pharmaceutical research and development, driving innovation and enhancing the capabilities of CMOs. Furthermore, advancements in manufacturing technology have enabled these organizations to meet the evolving demands of the global market efficiently. Together, these elements contribute to the dynamic growth and development of the Vietnam Oral Solid Dosage Contract Manufacturing Market, establishing it as an important component in the global pharmaceutical manufacturing sector.

Vietnam Oral Solid Dosage Contract Manufacturing Market Restraints

The Vietnam Oral Solid Dosage Contract Manufacturing Market, despite its growth, faces several restraints, including stringent regulatory compliance challenges, particularly in adhering to international standards like Good Manufacturing Practices (GMP). Intense competition from other low-cost manufacturing countries such as India and China, coupled with technological and infrastructural limitations, restricts Vietnam’s market expansion. Intellectual property concerns deter foreign investment, while a shortage of skilled pharmaceutical professionals hampers operational efficiency. Additionally, vulnerabilities in the supply chain, particularly regarding the import of raw materials, and market saturation leading to price pressures present further obstacles. These challenges underscore the need for strategic initiatives in regulatory adherence, technological advancement, workforce development, intellectual property protection, and supply chain optimization to enhance Vietnam’s competitiveness in the global pharmaceutical manufacturing arena. Top of Form

Vietnam Oral Solid Dosage Contract Manufacturing Market Opportunities

Expansion of Export Markets:

With its strategic geographical location and improving manufacturing capabilities, Vietnam has the potential to become a key exporter in the oral solid dosage pharmaceutical market. The country can leverage its cost advantages and improved quality standards to penetrate international markets, particularly in ASEAN countries, Africa, and Latin America.

Increasing Foreign Investment:

The market is poised to attract more foreign investment, thanks to Vietnam’s supportive government policies, economic stability, and ongoing efforts to align with international regulatory standards. This can lead to collaborations with multinational pharmaceutical companies and the establishment of more advanced manufacturing facilities.

Advancements in Pharmaceutical R&D:

There is significant scope for growth in pharmaceutical research and development. Investments in R&D can lead to the development of innovative drug formulations and manufacturing processes, enhancing the capabilities of Vietnamese CMOs and appealing to a broader range of clients.

Growing Domestic Pharmaceutical Market:

The rising healthcare awareness and increasing healthcare expenditure in Vietnam present opportunities for market expansion domestically. As the demand for pharmaceutical products grows within the country, local manufacturers can capitalize on this trend.

Technological Innovations:

Adopting cutting-edge technologies in drug manufacturing processes can position Vietnamese CMOs to compete more effectively on a global scale. There is a growing opportunity for the implementation of advanced technologies like AI and automation in manufacturing, leading to higher efficiency and quality.

Focus on Niche and Specialized Products:

Specializing in niche pharmaceutical products, such as high-potency active pharmaceutical ingredients (APIs) or complex drug formulations, can provide a competitive edge and open new market segments for Vietnamese CMOs.

Strengthening Supply Chain and Logistics:

Improving supply chain management and logistics can significantly enhance the operational efficiency of Vietnamese CMOs. This includes establishing robust raw material sourcing strategies and efficient distribution networks.

Partnerships and collaborations:

Strategic partnerships with global pharmaceutical companies, academic institutions, and research organizations can lead to knowledge transfer, technological advancements, and an expanded customer base. Top of Form

Interesting Facts About the Vietnam Oral Solid Dosage Contract Manufacturing Market

The global oral solid dosage contract manufacturing market was valued at USD 26,956.76 Million in 2023.
Tablets are the preferred solid dosage form, with estimated sales of more than USD 500,000 by the end of 2027.
Recent advances in drug delivery technology, such as targeted drug delivery and sustained release dosage forms, have increased the demand for oral controlled-release drug delivery technology.
The expansion of solid-dose pharmaceutical manufacturing is driven by new solid-dose formats and the increasing demand for OSD products.
CDMOs are investing in expanding OSD development, which is expected to increase the demand for oral controlled-release drug delivery technology.
There were 24 solid-dose tablets and 7 capsule solid-dose forms among the 59 new molecular entities.
Catalent recently completed a USD 1.2 billion regenerative medicine partnership with Paragon and is investing USD 40 million to increase tablet and capsule controlled-release production.
UPM Pharmaceuticals offers expert solid dose manufacturing and development services for clinical or commercial products, with efficiency-enhancing technologies for clinical trial supply and scale-up mechanisms.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Competitive Landscape

The competitive landscape of the Vietnam Oral Solid Dosage Contract Manufacturing market is characterized by the presence of several key players, each employing various strategies to strengthen their market position. These strategies include product innovation, mergers and acquisitions, expansion into new markets, and enhancing production capabilities. Some of the notable players in the Vietnam Oral Solid Dosage Contract Manufacturing market are:

DHG Pharmaceutical Joint Stock Company
Vietnam Pharmaceutical Corporation (Vinapharm)
Traphaco Joint Stock Company
Hau Giang Pharmaceutical
Mekophar Chemical Pharmaceutical
Pymepharco
OPV Pharmaceutical
Everpia JSC
Vimedimex Medi-Pharma
Imexpharm Corporation
Domesco Medical

Regional Analysis

The Vietnam Oral Solid Dosage Contract Manufacturing market exhibits distinct regional characteristics, with each area contributing uniquely to the sector’s landscape. Northern Vietnam, centered around Hanoi, boasts a concentration of pharmaceutical companies and CMOs, benefiting from close proximity to government bodies and a well-developed infrastructure. Central Vietnam is emerging as a potential growth area in the pharmaceutical sector, offering cost advantages and an evolving infrastructure, making it attractive for new investments. In contrast, southern Vietnam, particularly Ho Chi Minh City, serves as an economic powerhouse with advanced infrastructure, a skilled workforce, and excellent export-import facilities due to its proximity to major ports. These regional dynamics are shaped by factors such as infrastructure, availability of skilled labor, regulatory environments, and economic development levels, each playing a pivotal role in influencing the distribution capabilities, operational efficiency, and market growth potential of CMOs across Vietnam’s diverse landscape.

Segmentation

By Type Outlook
- Tablets
- Capsules
- Powders
- Granules
- Others (Lozenges, Gummies, Pastilles, etc.)
By Mechanism Outlook
- Immediate-release
- Delayed-release
- Controlled-release
By End-user Outlook
- Large-size Companies
- Medium- & Small-size Companies
- Others (Startups & Generic Pharmaceutical Companies)

Chapter No. 1 :………. Introduction.. 21

1.1. Report Description. 21

1.1.1. Purpose of the Report 21

1.1.2. USP & Key Offerings. 21

1.2. Key Benefits for Stakeholders. 21

1.3. Target Audience. 22

1.4. Report Scope 23

Chapter No. 2 :………. Executive Summary. 25

2.1. OSD Contract Manufacturing Market Snapshot. 25

2.2. Vietnam OSD Contract Manufacturing Market, 2018 – 2032 (USD Million) 26

Chapter No. 3 :………. Geopolitical Crisis Impact Analysis. 27

3.1. Russia-Ukraine and Israel-Palestine War Impacts. 27

3.1.1. Geopolitical Instability. 27

3.1.2. Supply chain disruptions. 27

3.1.3. Regulatory Challenges. 27

3.1.4. Economic Impact 27

3.1.5. Vietnam Market Dynamics. 27

Chapter No. 4 :………. OSD Contract Manufacturing Market – Industry Analysis. 28

4.1. Introduction 28

4.2. Market Drivers 29

4.2.1. Complexity of New Molecules. 29

4.2.2. Advances in Drug Delivery. 29

4.2.3. Growing Demand for Oral Solid Dosages. 29

4.2.4. Expansion of Manufacturing Units. 30

4.2.5. Patent Expiry and Increasing Demand For Generic Drugs 30

4.3. Market Restraints. 31

4.3.1. Stringent Government Regulations. 31

4.3.2. High Competition among CDMOs. 31

4.3.3. Cultural Gaps and Time Zones. 31

4.4. Market Opportunities. 32

4.4.1. Technological Advancements. 32

4.4.2. Particle Engineering. 32

4.4.3. Mergers and Collaborations with Pharma and Biotech Firms. 32

4.4.4. Flexible Business Models. 32

4.5. Porter’s Five Forces Analysis. 33

4.6. Value Chain Analysis. 35

Chapter No. 5 :………. Competitive Landscape Analysis. 36

5.1. Company Market Share Analysis – 2023. 36

5.1.1. Vietnam OSD Contract Manufacturing Market: Company Market Share, by Revenue, 2023. 36

5.1.2. Vietnam OSD Contract Manufacturing Market: Top 6 Company Market Share, by Revenue, 2023. 37

5.1.3. Vietnam OSD Contract Manufacturing Market: Top 3 Company Market Share, by Revenue, 2023. 38

5.1. Vietnam OSD Contract Manufacturing Market Company Revenue Market Share, 2023. 39

5.2. Company Assessment Metrics, 2023. 40

5.2.1. Stars 40

5.2.2. Emerging Leaders. 40

5.2.3. Pervasive Players. 40

5.2.4. Participants. 41

5.3. Strategic Developments. 41

5.3.1. Acquisitions & Mergers. 41

5.3.2. Agreements & Collaborations. 43

5.3.3. Expansion. 44

5.4. Key Players Product Matrix. 45

Chapter No. 6 :………. PESTEL & Adjacent Market Analysis. 49

6.1. PESTEL 49

6.1.1. Political Factors. 49

6.1.2. Economic Factors. 49

6.1.3. Social Factors. 49

6.1.4. Technological Factors. 49

6.1.5. Environmental Factors. 50

6.1.6. Legal Factors. 50

6.2. Adjacent Market Analysis. 51

Chapter No. 7 :………. OSD Contract Manufacturing Market – By Type Segment Analysis. 53

7.1. OSD Contract Manufacturing Market Overview, by Type Segment. 53

7.1.1. Key Types. 53

7.1.2. OSD Contract Manufacturing Market Revenue Share, By Type, 2023 & 2032. 54

7.1.3. OSD Contract Manufacturing Market Attractiveness Analysis, By Type. 55

7.1.4. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032. 56

7.1.5. OSD Contract Manufacturing Market Revenue, By Type, 2018, 2023, 2027 & 2032. 57

7.2. Tablets 58

7.3. Capsules 59

7.4. Powders 60

7.5. Granules 61

7.6. Others 62

Chapter No. 8 :………. OSD Contract Manufacturing Market – By Mechanism Segment Analysis. 63

8.1. OSD Contract Manufacturing Market Overview, by Mechanism Segment 63

8.1.1. Key Mechanism Segments. 63

8.1.2. OSD Contract Manufacturing Market Revenue Share, By Mechanism, 2023 & 2032. 64

8.1.3. OSD Contract Manufacturing Market Attractiveness Analysis, By Mechanism.. 65

8.1.4. Incremental Revenue Growth Opportunity, by Mechanism, 2024 – 2032. 66

8.1.5. OSD Contract Manufacturing Market Revenue, By Mechanism, 2018, 2023, 2027 & 2032. 67

8.2. Immediate Release. 68

8.3. Delayed Release. 69

8.4. Controlled Release. 70

Chapter No. 9 :………. OSD Contract Manufacturing Market – By End-user Segment Analysis. 71

9.1. OSD Contract Manufacturing Market Overview, by End-user Segment 71

9.1.1. Key End-user Segments. 71

9.1.2. OSD Contract Manufacturing Market Revenue Share, By End-user, 2023 & 2032. 72

9.1.3. OSD Contract Manufacturing Market Attractiveness Analysis, By End-user. 73

9.1.4. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032. 74

9.1.5. OSD Contract Manufacturing Market Revenue, By End-user, 2018, 2023, 2027 & 2032. 75

9.2. Large Companies. 76

9.3. SMEs 77

Chapter No. 10 :…….. OSD Contract Manufacturing Market – By Therapeutic Area Segment Analysis. 78

10.1. OSD Contract Manufacturing Market Overview, by Therapeutic Area Segment 78

10.1.1. Key Therapeutic Area Segments. 78

10.1.2. OSD Contract Manufacturing Market Revenue Share, By Therapeutic Area, 2023 & 2032. 79

10.1.3. OSD Contract Manufacturing Market Attractiveness Analysis, By Therapeutic Area. 80

10.1.4. Incremental Revenue Growth Opportunity, by Therapeutic Area, 2024 – 2032. 81

10.1.5. OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032. 82

10.2. Cardiovascular 83

10.3. CNS 84

10.4. Gastrointestinal 85

10.5. Oncology 86

10.6. Others 87

Chapter No. 11 :…….. OSD Contract Manufacturing Market – Vietnam… 88

11.1. Vietnam 88

11.2. Key Highlights 89

11.2.1. Vietnam 90

11.2.1.1. Vietnam OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 90

11.2.1.2. Vietnam OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 91

11.2.1.3. Vietnam OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 92

11.2.1.4. Vietnam OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 93

Chapter No. 12 :…….. Company Profiles. 94

12.1. DHG Pharmaceutical Joint Stock Company. 94

12.1.1. Company Overview.. 94

12.1.2. Product Portfolio. 95

12.1.3. Financial Overview.. 95

12.2. Vietnam Pharmaceutical Corporation (Vinapharm) 96

12.2.1. Company Overview.. 96

12.2.2. Product Portfolio. 97

12.2.3. Financial Overview.. 97

12.3. Traphaco Joint Stock Company. 98

12.3.1. Company Overview.. 98

12.3.2. Product Portfolio. 99

12.3.3. Financial Overview.. 99

12.4. Hau Giang Pharmaceutical 100

12.4.1. Company Overview.. 100

12.4.2. Product Portfolio. 101

12.4.3. Financial Overview.. 101

12.5. Mekophar Chemical Pharmaceutical 102

12.5.1. Company Overview.. 102

12.5.2. Product Portfolio. 103

12.5.3. Financial Overview.. 103

12.6. Pymepharco 104

12.6.1. Company Overview.. 104

12.6.2. Product Portfolio. 105

12.6.3. Financial Overview.. 105

12.7. OPV Pharmaceutical 106

12.7.1. Company Overview.. 106

12.7.2. Product Portfolio. 106

12.7.3. Financial Overview.. 107

12.8. Everpia JSC 108

12.8.1. Company Overview.. 108

12.8.2. Product Portfolio. 108

12.8.3. Financial Overview.. 109

12.9. Vimedimex Medi-Pharma. 110

12.9.1. Company Overview.. 110

12.9.2. Product Portfolio. 111

12.9.2.1. Financial Overview.. 111

12.10. Imexpharm Corporation. 112

12.10.1. Company Overview.. 112

12.10.2. Product Portfolio. 113

12.10.3. Financial Overview.. 113

12.11. Domesco Medical 114

12.11.1. Company Overview.. 114

12.11.2. Product Portfolio. 115

12.11.3. Financial Overview.. 115

Chapter No. 13 :…….. Research Methodology. 124

13.1. Research Methodology. 124

13.2. Phase I – Secondary Research. 125

13.3. Phase II – Data Modeling. 125

13.3.1. Company Share Analysis Model 126

13.3.2. Revenue Based Modeling. 126

13.4. Phase III – Primary Research. 127

13.5. Research Limitations. 128

13.5.1. Assumptions. 128

List of Figures

FIG NO. 1……….. Vietnam OSD Contract Manufacturing Market Revenue, 2018 – 2032 (USD Million) 26

FIG NO. 2……….. Porter’s Five Forces Analysis for Vietnam OSD Contract Manufacturing Market 33

FIG NO. 3……….. Value Chain Analysis for Vietnam OSD Contract Manufacturing Market 35

FIG NO. 4……….. Company Share Analysis, 2023. 36

FIG NO. 5……….. Company Share Analysis, 2023. 37

FIG NO. 6……….. Company Share Analysis, 2023. 38

FIG NO. 7……….. OSD Contract Manufacturing Market – Company Revenue Market Share, 2023. 39

FIG NO. 8……….. Company Assessment Metrics. 40

FIG NO. 9……….. OSD Contract Manufacturing Market Revenue Share, By Type, 2023 & 2032. 54

FIG NO. 10……… Market Attractiveness Analysis, By Type. 55

FIG NO. 11……… Incremental Revenue Growth Opportunity by Type, 2024 – 2032. 56

FIG NO. 12……… OSD Contract Manufacturing Market Revenue, By Type, 2018, 2023, 2027 & 2032. 57

FIG NO. 13……… Vietnam OSD Contract Manufacturing Market for Tablets, Revenue (USD Million) 2018 – 2032. 58

FIG NO. 14……… Vietnam OSD Contract Manufacturing Market for Capsules, Revenue (USD Million) 2018 – 2032. 59

FIG NO. 15……… Vietnam OSD Contract Manufacturing Market for Powders, Revenue (USD Million) 2018 – 2032. 60

FIG NO. 16……… Vietnam OSD Contract Manufacturing Market for Granules, Revenue (USD Million) 2018 – 2032. 61

FIG NO. 17……… Vietnam OSD Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032. 62

FIG NO. 18……… OSD Contract Manufacturing Market Revenue Share, By Mechanism, 2023 & 2032. 64

FIG NO. 19……… Market Attractiveness Analysis, By Mechanism.. 65

FIG NO. 20……… Incremental Revenue Growth Opportunity by Mechanism, 2024 – 2032. 66

FIG NO. 21……… OSD Contract Manufacturing Market Revenue, By Mechanism, 2018, 2023, 2027 & 2032. 67

FIG NO. 22……… Vietnam OSD Contract Manufacturing Market for Immediate Release, Revenue (USD Million) 2018 – 2032. 68

FIG NO. 23……… Vietnam OSD Contract Manufacturing Market for Delayed Release, Revenue (USD Million) 2018 – 2032. 69

FIG NO. 24……… Vietnam OSD Contract Manufacturing Market for Controlled Release, Revenue (USD Million) 2018 – 2032. 70

FIG NO. 25……… OSD Contract Manufacturing Market Revenue Share, By End-user, 2023 & 2032. 72

FIG NO. 26……… Market Attractiveness Analysis, By End-user 73

FIG NO. 27……… Incremental Revenue Growth Opportunity by End-user, 2024 – 2032. 74

FIG NO. 28……… OSD Contract Manufacturing Market Revenue, By End-user, 2018, 2023, 2027 & 2032. 75

FIG NO. 29……… Vietnam OSD Contract Manufacturing Market for Large Companies, Revenue (USD Million) 2018 – 2032. 76

FIG NO. 30……… Vietnam OSD Contract Manufacturing Market for SMEs, Revenue (USD Million) 2018 – 2032. 77

FIG NO. 31……… OSD Contract Manufacturing Market Revenue Share, By Therapeutic Area, 2023 & 2032. 79

FIG NO. 32……… Market Attractiveness Analysis, By Therapeutic Area. 80

FIG NO. 33……… Incremental Revenue Growth Opportunity by Therapeutic Area, 2024 – 2032. 81

FIG NO. 34……… OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032. 82

FIG NO. 35……… Vietnam OSD Contract Manufacturing Market for Cardiovascular, Revenue (USD Million) 2018 – 2032. 83

FIG NO. 36……… Vietnam OSD Contract Manufacturing Market for CNS, Revenue (USD Million) 2018 – 2032. 84

FIG NO. 37……… Vietnam OSD Contract Manufacturing Market for Gastrointestinal, Revenue (USD Million) 2018 – 2032. 85

FIG NO. 38……… Vietnam OSD Contract Manufacturing Market for Oncology, Revenue (USD Million) 2018 – 2032. 86

FIG NO. 39……… Vietnam OSD Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032. 87

FIG NO. 40……… Vietnam OSD Contract Manufacturing Market Revenue, 2018 – 2023 (USD Million) 88

FIG NO. 41……… Research Methodology – Detailed View.. 124

FIG NO. 42……… Research Methodology. 125

List of Tables

TABLE NO. 1. :…. Vietnam OSD Contract Manufacturing Market: Snapshot 21

TABLE NO. 2. :…. Drivers for the OSD Contract Manufacturing Market: Impact Analysis. 25

TABLE NO. 3. :…. Restraints for the OSD Contract Manufacturing Market: Impact Analysis. 27

TABLE NO. 4. :…. Vietnam OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 86

TABLE NO. 5. :…. Vietnam OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 86

TABLE NO. 6. :…. Vietnam OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 87

TABLE NO. 7. :…. Vietnam OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 87

TABLE NO. 8. :…. Vietnam OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 88

TABLE NO. 9. :…. Vietnam OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 88

TABLE NO. 10. :.. Vietnam OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 89

TABLE NO. 11. :.. Vietnam OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 89

What is the projected market size of the Vietnam Oral Solid Dosage Contract Manufacturing market by 2032?

The Vietnam Oral Solid Dosage Contract Manufacturing market is expected to reach USD 190.57 million by 2032.

What is the Compound Annual Growth Rate (CAGR) of the Vietnam Oral Solid Dosage Contract Manufacturing market between 2023 and 2032?

The market is projected to grow at a CAGR of 6.68% from 2023 to 2032.

What are the key drivers for the growth of the Vietnam Oral Solid Dosage Contract Manufacturing market?

Key drivers include the rising demand for generic drugs, cost-effective manufacturing capabilities, supportive government policies, advancements in pharmaceutical R&D, and the strategic geographic location of Vietnam.

What challenges does the Vietnam Oral Solid Dosage Contract Manufacturing market face?

Major challenges include stringent regulatory compliance, competition from other low-cost manufacturing countries, technological and infrastructural limitations, intellectual property concerns, skilled workforce shortages, supply chain vulnerabilities, and market saturation leading to price pressures.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –